Current Grantees
Learn about the OCRA grantees creating a brighter future for everyone touched by ovarian and related gynecologic cancers.
Support Cancer Research Funding: Sponsor a Scientist
Sponsor a Scientist
Funding OCRA’s scientific research initiatives is one of the most powerful ways to support our life-saving work.
Contribute to Groundbreaking Research
Our Partners in Science program allows you to directly contribute to groundbreaking research aimed at preventing ovarian and related gynecologic cancers, developing better, more effective treatments, and ultimately finding a cure.
Program Details
The OCRA Partners in Science program offers donors a unique opportunity to sponsor specific scientists based on personalized criteria, fostering a meaningful connection between donors and researchers. The minimum contribution is $20,000.
-
Donors choose scientists to sponsor based on factors like geographic location, institution, or area of study. Sponsored researchers are selected from projects reviewed and approved annually by OCRA’s Scientific Advisory Committee (SAC).
-
Donors can review detailed grant information, including project summaries, abstracts, or full proposals. There’s ongoing communication between donors and researchers, with possibilities for personalized lab tours. Donors also receive regular updates on research progress, final summaries, annual reports, and publications resulting from the research.
-
Donors can sponsor multiple investigators depending on the contribution amount or co-sponsor a research project with others.
-
The program is open to individual donors, private family foundations, organizations, community events, and groups of friends or relatives supporting research on behalf of a loved one. OCRA staff provide guidance throughout the selection process, ensuring a meaningful and personal experience.
-
Donors’ support is acknowledged on the OCRA website, and grants can be named in honor or in memory of a loved one.
Partners in Science Donors
We are immensely grateful to the donors who sponsor our gifted scientists. WIthout their generosity, this program would not be possible.
Become a Partner in Science
To learn more about becoming an OCRA Partner in Science, please contact Jon Zeidman, Chief Development Officer, at jzeidman@ocrahope.org or 212-268-1002.
Related Topics
FDA Approves First Ovarian Cancer Immunotherapy for PD-L1–Positive Platinum-Resistant Disease
The U.S. Food and Drug Administration (FDA) has approved the first immunotherapy regimen shown to extend survival in a subset of ovarian cancer patients. The FDA authorized Keytruda (pembrolizumab), made by Merck, in combination with chemotherapy, for PD-L1–positive, platinum-resistant epithelial ovarian, fallopian tube, and primary peritoneal cancers. Keytruda plus weekly Taxol (paclitaxel), with or without … Continued
New Support Sessions for the Gynecologic Cancer Community
Ovarian Cancer Research Alliance (OCRA) has expanded its free, online support offerings with several new weekly sessions for individuals diagnosed with gynecologic cancers, as well as caregivers and family members. These include cervical, vaginal, and vulvar cancer support, caregiver grief support, Spanish-language sessions, and creative wellness programs. OCRA’s support sessions are facilitated by oncology social work professionals. … Continued
OCRA Announces Collaboration with OPERATION WIPE OUT
NEW YORK, NY — [February 5, 2026] — Ovarian Cancer Research Alliance (OCRA) has announced a collaboration with OPERATION WIPE OUT, an initiative that has demonstrated meaningful success reducing cervical cancer risk in Alabama through prevention-focused education and access to care. Drawing on this proven public-health framework, OCRA will adapt and expand the model nationwide—bringing practical, evidence-based … Continued